A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome (Q39246847)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome |
scientific article |
Statements
1 reference
A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome (English)
1 reference
Ritu Lal
1 reference
Aaron Ellenbogen
1 reference
Dan Chen
1 reference
Katie Zomorodi
1 reference
Harisha Atluri
1 reference
Wendy Luo
1 reference
James Tovera
1 reference
Janet Hurt
1 reference
Daniel Bonzo
1 reference
Marie-Liesse Lassauzet
1 reference
Amanda Vu
1 reference
Kenneth C Cundy
1 reference
1 July 2012
1 reference
1 reference
35
1 reference
4
1 reference
165-173
1 reference
Identifiers
1 reference
1 reference